CANINE IgG NUCLEIC ACID MOLECULES
OwnerCatherine A. McCall, Liang Tanginventors
Life of this patent
Estimating the term…
Loading patent…
OwnerCatherine A. McCall, Liang Tanginventors
Estimating the term…
The invention relates to canine immunoglobulin G (IgG) and canine interleukin-13 receptors (IL-13R) as well as fusion proteins containing canine IgG and/or canine IL-13R. In particular, the present invention discloses nucleic acid molecules encoding canine IgG, including species-specific regions of the heavy chain of canine IgG, and canine IL-13R alpha chain (IL-13Rα) proteins, particularly canine interleuken receptor alpha 1 (IL-13Rα1) and canine interleuken receptor alpha 2 (IL-13Rα2) proteins. Also included are canine IgG and IL-13Rα proteins, antibodies having selectivity for such proteins, inhibitors of such proteins and/or nucleic acid molecules, cells transformed with said nucleic acid molecules, assays employing such cells, nucleic acids molecules, proteins, antibodies and/or inhibitors, and therapeutic compositions comprising said nucleic acids molecules, proteins, antibodies and/or inhibitors. Also included are kits containing said molecules or chimera thereof, including their use to evaluate and regulate an immune response in an animal.
1-59. (canceled)
An isolated nucleic acid molecule selected from the group consisting of:
An isolated nucleic acid molecule selected from the group consisting of:
Dependencies are inferred from the claim text.